Mason, OH, United States of America

Raymond S Gross

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hoechst Marion Roussel. Active years: 1999.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Raymond S Gross

Introduction: Raymond S Gross is a notable inventor based in Mason, Ohio, recognized for his work in the field of pharmacology. His significant contributions include the development of NMDA antagonists, which have valuable applications in medical treatments.

Latest Patents: Raymond S Gross holds a patent for his invention related to NMDA (N-methyl-D-aspartate) antagonists. This invention introduces new excitatory amino acid antagonists, referred to in his patent as compounds of formula (1). These innovative antagonists are designed to serve as NMDA blockers, offering potential therapeutic benefits in various neurological conditions.

Career Highlights: Throughout his career, Raymond has served as a vital member of Hoechst Marion Roussel, an esteemed company in the pharmaceutical industry. His work has contributed to the advancement of medical science and has positioned him as an influential figure among inventors in his field.

Collaborations: In his pursuit of innovation, Raymond S Gross has collaborated with talented professionals, including Boyd L Harrison and Bruce M Baron. Together, they have worked towards the development of groundbreaking inventions that push the boundaries of current therapeutic approaches.

Conclusion: Raymond S Gross exemplifies the spirit of innovation through his dedication to developing impactful medical solutions. His patent for NMDA antagonists showcases his commitment to advancing scientific knowledge and improving healthcare outcomes. As he continues his work at Hoechst Marion Roussel, the contributions of this inventive mind are sure to inspire future breakthroughs in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…